11.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Precedente Chiudi:
$12.38
Aprire:
$12.27
Volume 24 ore:
955.03K
Relative Volume:
2.33
Capitalizzazione di mercato:
$692.04M
Reddito:
$217.25M
Utile/perdita netta:
$-50.92M
Rapporto P/E:
-11.74
EPS:
-1
Flusso di cassa netto:
$-100.85M
1 W Prestazione:
-7.19%
1M Prestazione:
-25.74%
6M Prestazione:
-29.49%
1 anno Prestazione:
-55.11%
Prothena Corporation Plc Stock (PRTA) Company Profile
Nome
Prothena Corporation Plc
Settore
Industria
Telefono
011-353-1-236-2500
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Confronta PRTA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PRTA
Prothena Corporation Plc
|
11.74 | 692.04M | 217.25M | -50.92M | -100.85M | -1.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
2024-01-30 | Downgrade | BofA Securities | Buy → Neutral |
2023-12-12 | Iniziato | Deutsche Bank | Buy |
2023-04-24 | Iniziato | SVB Securities | Outperform |
2023-01-27 | Iniziato | Piper Sandler | Overweight |
2022-11-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-09-28 | Aggiornamento | BofA Securities | Neutral → Buy |
2021-11-19 | Iniziato | JMP Securities | Mkt Outperform |
2021-06-18 | Aggiornamento | BofA Securities | Underperform → Neutral |
2021-06-08 | Reiterato | Oppenheimer | Outperform |
2021-05-26 | Iniziato | Citigroup | Buy |
2021-02-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2021-02-12 | Aggiornamento | Jefferies | Hold → Buy |
2021-02-02 | Aggiornamento | BTIG Research | Neutral → Buy |
2020-12-07 | Iniziato | H.C. Wainwright | Buy |
2020-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
2019-11-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
2018-05-21 | Downgrade | Barclays | Equal Weight → Underweight |
2018-04-23 | Downgrade | Jefferies | Buy → Hold |
2018-04-05 | Reiterato | Barclays | Overweight |
2017-11-20 | Downgrade | Wedbush | Outperform → Neutral |
2017-09-29 | Reiterato | BTIG Research | Buy |
2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
2017-08-17 | Iniziato | Evercore ISI | Outperform |
2017-07-11 | Iniziato | Jefferies | Buy |
2017-04-12 | Iniziato | Cantor Fitzgerald | Overweight |
2017-04-12 | Iniziato | Piper Jaffray | Overweight |
2017-03-02 | Iniziato | Instinet | Buy |
2016-12-21 | Iniziato | SunTrust | Buy |
2016-11-03 | Iniziato | Deutsche Bank | Buy |
2016-08-04 | Reiterato | Barclays | Overweight |
2016-05-13 | Iniziato | Barclays | Overweight |
2016-02-19 | Reiterato | Wedbush | Outperform |
2016-01-21 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Amundi Has $28,000 Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
(PRTA) Technical Data - news.stocktradersdaily.com
Bank of New York Mellon Corp Has $2.08 Million Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00 - Defense World
Zacks Research Has Positive Outlook of Prothena Q1 Earnings - Defense World
Insider Sell: Chief Medical Officer Hideki Garren Sells 2,000 Sh - GuruFocus.com
Zacks Research Weighs in on Prothena FY2027 Earnings - Defense World
Trend Tracker for (PRTA) - Stock Traders Daily
Recent Analysts’ Ratings Changes for Prothena (PRTA) - Defense World
Rhumbline Advisers Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Handelsbanken Fonder AB - Defense World
Prothena Corporation: Multiple Failures Make It Risky (NASDAQ:PRTA) - Seeking Alpha
Prothena (NASDAQ:PRTA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World
PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView
Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus - MSN
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential By Investing.com - Investing.com South Africa
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential - Investing.com India
Prothena (NASDAQ:PRTA) Rating Increased to Hold at StockNews.com - Defense World
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga
Prothena’s (PRTA) “Buy” Rating Reiterated at HC Wainwright - Defense World
Prothena’s (PRTA) “Buy” Rating Reiterated at Chardan Capital - Defense World
Analysts Set Prothena Co. plc (NASDAQ:PRTA) PT at $46.50 - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for Prothena (NASDAQ:PRTA) - Defense World
Royal Bank of Canada Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock Price - Defense World
Prothena Corporation plc (NASDAQ:PRTA) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St
Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript - Insider Monkey
RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk - Marketscreener.com
Prothena Corporation (NASDAQ: PRTA) Gears Up for Transformational 2025 with Key Clinical Milestones - Pradesh Tak
Earnings call transcript: Prothena's Q4 2024 results highlight innovation By Investing.com - Investing.com Australia
Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ... - Yahoo Finance
Earnings call transcript: Prothena's Q4 2024 results highlight innovation - Investing.com
Prothena: Q4 Earnings Snapshot -February 20, 2025 at 04:23 pm EST - Marketscreener.com
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights - Business Wire
(PRTA) Trading Advice - Stock Traders Daily
Prothena Corporation PLC expected to post a loss of $1.04 a shareEarnings Preview - TradingView
Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm - EIN News
The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News
Merck KGaA bids for SpringWorks (SWTX), Evolus (EOLS) receives FDA nod & Prothena (PRTA) struggles - substack.com
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Business Wire
Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight - GlobeNewswire Inc.
Focused Wealth Management Inc Makes New Investment in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Critical Survey: Prothena (NASDAQ:PRTA) vs. Annexon (NASDAQ:ANNX) - Defense World
Prothena (PRTA) to Release Quarterly Earnings on Thursday - Defense World
Prothena (NASDAQ:PRTA) Given New $62.00 Price Target at Oppenheimer - MarketBeat
KALA BIO (NASDAQ:KALA) and Prothena (NASDAQ:PRTA) Financial Survey - Defense World
Prothena (NASDAQ:PRTA) Price Target Raised to $62.00 - Defense World
Form S-8Securities to be offered to employees in employee benefit plans - br.ADVFN.com
Learn to Evaluate (PRTA) using the Charts - Stock Traders Daily
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings) - Benzinga
Prothena Corporation Plc Azioni (PRTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):